Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtre
1.
Braz. j. phys. ther. (Impr.) ; 19(3): 167-176, May-Jun/2015. tab
Article Dans Anglais | LILACS | ID: lil-751381

Résumé

Introduction: Patellofemoral pain syndrome (PFPS) is characterized by anterior knee pain, which may limit the performance of functional activities. The influence of hip joint motion on the development of this syndrome has already been documented in the literature. In this regard, studies have investigated the effectiveness of hip muscle strengthening in patients with PFPS. Objectives: The aims of this systematic review were (1) to summarize the literature related to the effects of hip muscle strengthening on pain intensity, muscle strength, and function in individuals with PFPS and (2) to evaluate the methodological quality of the selected studies. Method: A search for randomized controlled clinical trials was conducted using the following databases: Google Scholar, MEDLINE, PEDro, LILACS, and SciELO. The selected studies had to distinguish the effects of hip muscle strengthening in a group of patients with PFPS, as compared to non-intervention or other kinds of intervention, and had to investigate the following outcomes: pain, muscle strength, and function. The methodological quality of the selected studies was analyzed by means of the PEDro scale. Results: Seven studies were selected. These studies demonstrated that hip muscle strengthening was effective in reducing pain. However, the studies disagreed regarding the treatments' ability to improve muscle strength. Improvement in functional capabilities after hip muscle strengthening was found in five studies. Conclusion: Hip muscle strengthening is effective in reducing the intensity of pain and improving functional capabilities in patients with PFPS, despite the lack of evidence for its ability to increase muscle strength. .


Sujets)
Animaux , Femelle , Rats , Voies afférentes/physiologie , Muscles squelettiques/physiologie , Plasticité neuronale/physiologie , Nociception/physiologie , Réflexe/physiologie , Peau/innervation , Analgésiques non narcotiques/pharmacologie , Bupivacaïne/pharmacologie , Dexmédétomidine/pharmacologie , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Potentiels évoqués somatosensoriels/physiologie , Muscles squelettiques/effets des médicaments et des substances chimiques , Conduction nerveuse/effets des médicaments et des substances chimiques , Plasticité neuronale/effets des médicaments et des substances chimiques , Nociception/effets des médicaments et des substances chimiques , Stimulation physique/effets indésirables , Rat Sprague-Dawley , Récepteurs facteur croissance nerf/métabolisme , Réflexe/effets des médicaments et des substances chimiques , Somatostatine/métabolisme , Moelle spinale/effets des médicaments et des substances chimiques , Moelle spinale/métabolisme , Ubiquitin thiolesterase/métabolisme
2.
Arq. bras. endocrinol. metab ; 58(4): 369-376, 06/2014. tab, graf
Article Dans Anglais | LILACS | ID: lil-711627

Résumé

Objective: To evaluate the effect of sitagliptin on somatosensory-evoked potentials (SEPs) and metabolic control in patients with type 2 diabetes mellitus without clinical diabetic neuropathy. Materials and methods: Interventional, prospective, and open study. Patients with less than six months from the diagnosis were included. Examinations of SEPs and laboratory tests at fasting and after food stimulation were performed before and after three months of treatment with sitagliptin (100 mg/day). Results: There was a reduction in the mean levels of HbA1c (P < 0.0001), fasting glucose (P = 0.001), total cholesterol (P = 0.019), and ALT (P = 0.022). An increase in active GLP-1 was found at the end of the study (P = 0.0025). Several SEPs showed statistically significant differences when analyzed before and after treatment with sitagliptin. Conclusion: The results give a glimpse of the possible use of sitagliptin in the treatment of some neurodegenerative conditions of the peripheral nervous system, in addition to its already established role in glycemic control. .


Objetivo: Avaliar o efeito da sitagliptina nos potenciais evocados somatossensoriais (PESS) e controle metabólico de pacientes com diabetes melito tipo 2, sem neuropatia diabética. Materiais e métodos: Estudo de intervenção, prospectivo e aberto. Os pacientes com menos de seis meses de diagnóstico foram incluídos. Exames dos PESS e testes laboratoriais em jejum e após a estimulação com alimentos foram realizados antes e depois de três meses de tratamento com sitagliptina (100 mg/dia). Resultados: Houve redução nos níveis médios de HbA1c (P < 0,0001), glicemia de jejum (P = 0,001), colesterol total (P = 0,019) e ALT (P = 0,022). Verificou-se aumento de GLP-1 ativo (P = 0,0025). Vários PESS mostraram diferenças estatisticamente significativas quando os valores foram analisados antes e após o tratamento com sitagliptina. Conclusão: Os resultados vislumbram a possível utilização de sitagliptina no tratamento de algumas condições neurodegenerativas do sistema nervoso periférico, em adição ao seu papel no controle glicêmico. .


Sujets)
Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , /traitement médicamenteux , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Hypoglycémiants/usage thérapeutique , Pyrazines/usage thérapeutique , Triazoles/usage thérapeutique , Activation métabolique , Aire sous la courbe , Alanine transaminase/sang , Aspartate aminotransferases/sang , Glycémie/analyse , Cholestérol/sang , /métabolisme , /physiopathologie , Aliment formulé , Jeûne/métabolisme , Glucagon-like peptide 1/sang , Hémoglobine glyquée/analyse , Études prospectives , Statistique non paramétrique , Triglycéride/sang , gamma-Glutamyltransferase/sang
3.
Journal of Veterinary Science ; : 97-101, 2003.
Article Dans Anglais | WPRIM | ID: wpr-36634

Résumé

The aim of this study is to investigate the effects of electroacupuncture, corticosteroid, and combination of two treatments on ambulatory paresis due to spinal cord injury in dogs by comparing therapeutic effects of electroacupuncture and corticosteroid. Spinal cord injury was induced in twenty healthy dogs (2.5~7 kg and 2~4 years) by foreign body insertion which compressed about 25% of spinal cord. There was no conscious proprioception, no extensor postural thrust, and ambulatory. Dogs were divided into four groups according to the treatment; corticosteroid (group A), electroacupuncture (group B), corticosteroid and electroacupuncture (group AB), and control (group C). Neurological examination was performed everyday to evaluate the spinal cord dysfunction until motor functions were returned to normal. Somatosensory evoked potentials (SEPs) were measured for objective and accurate evaluations. The latency in measured potentials was converted into the velocity for the evaluation of spinal cord dysfunctions. Pain perceptions were normal from pre-operation to 5 weeks after operation. Recovery days of conscious proprioception in groups A, B, AB, and C were 21.2+/-8.5 days, 19.8+/-4.3 days, 8.2+/-2.6 days, and 46.6+/-3.7 days, respectively. Recovery days of extensor postural thrust in group A, group B, group AB, and group C were 12.8+/-6.8 days, 13.8+/-4.8 days, 5.4+/-1.8 days, and 38.2+/-4.2 days, respectively. There were no significant differences between group A and group B. However, recovery days of group AB was significantly shorter than that of other groups and that of group C was significantly delayed (p<0.05). Conduction velocities of each group were significantly decreased after induction of spinal cord injury on SEPs (p<0.05) and they showed a tendency to return to normal when motor functions were recovered. According to these results, it was considered that the combination of corticosteroid and electroacupuncture was the most therapeutically effective for ambulatory paresis due to spinal cord injury in dogs.


Sujets)
Animaux , Chiens , Femelle , Mâle , Anti-inflammatoires/usage thérapeutique , Électroacupuncture/médecine vétérinaire , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Méthylprednisolone succinate/pharmacologie , Moelle spinale/effets des médicaments et des substances chimiques , Syndrome de compression médullaire/traitement médicamenteux
4.
Rev. méd. hondur ; 66(4): 135-40, oct.-dic. 1998. tab, graf
Article Dans Espagnol | LILACS | ID: lil-274083

Résumé

El objetivo de este estudio fue determinar las caracteristicas nutricionales, psicológicas y neurofisiológicas en escolares con niveles tóxicos de plomo en sangre para establecer la magnitud del problema. Los niños fueron seleccionados de estudios epidemiológicos de niveles de plomo séricos distribuyéndolos en dos grupos cuyas carácteristicas fueron: escolares de escuelas públicas de Tegucigalpa, de 6 a 8 años de edad, y nivel socioeconómico similar. Los grupos fueron conformados así: grupo 1) niños con niveles séricos de plomo mayores o iguales a 10 ug/dl (niños casos) y grupo 2) niños con niveles séricos de plomo menores o iguales a 2.9 ug/dl (niños controles). Se realizó examen clínico y físico, hematológico completo, test de inteligencia con la escala de Weschler y potenciales evocados somatosensoriales. La muestra fue de 22 niños: 11 niños casos y 11 niños controles. En los resultados, los niños con niveles tóxicos de plomo presentaban menor estatura, menor desempeño en la escala verbal de coeficiente intelectual y un mayor tiempo de conducción en la zona registrada por N20-P22, área asociativa cerebral (p=0.041). La hemoglobina, la velocidad de conducción periférica y el tiempo de conducción periférica y el tiempo de conducción del sistema nervioso central de N9 a N20, no fueron diferentes significativamente entre los dos grupos


Sujets)
Humains , Mâle , Femelle , Sous-performance , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Potentiels évoqués somatosensoriels/physiologie , Intoxication par le plomb/complications , Intoxication par le plomb/diagnostic , Intoxication par le plomb/épidémiologie
5.
Indian J Physiol Pharmacol ; 1996 Oct; 40(4): 372-6
Article Dans Anglais | IMSEAR | ID: sea-107210

Résumé

Somatosensory evoked potentials (SEPs) on median nerve stimulation were studied in 38 rubber factory workers to detect possible subclinical impairments in the somatosensory pathway as a result of exposure to rubber factory chemicals. Results showed trend towards the prolongation of latencies of all the major peaks of SEP such as P1, N1, P2, N2, P3, N3 in exposed workers besides changes in peak to peak amplitudes (higher P1-N1 and lower N2-P3). These changes may be attributed to synergistic action of solvents and other rubber factory chemicals on the generators of SEPs located higher up at the thalamo-cortical level.


Sujets)
Adolescent , Adulte , Stimulation électrique , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Humains , Industrie , Mâle , Nerf médian/effets des médicaments et des substances chimiques , Adulte d'âge moyen , Exposition professionnelle , Temps de réaction , Caoutchouc
6.
Yonsei Medical Journal ; : 397-401, 1995.
Article Dans Anglais | WPRIM | ID: wpr-125327

Résumé

The cause of premature ejaculation (PE) has been thought to be psychological in the majority of patients but we investigated penile hypersensitivity for an organic basis of PE. For another organic basis of PE, we have suggested hyperexcitability of the ejaculation center. SS-cream is a topical agent containing 9 oriental herbs for treating PE. Clinically SS-cream has been effective in the treatment of PE. Therefore, in order to implicate the organic basis of PE and realize the effect of SS-cream on PE, we investigated the somatosensory evoked potential (SEP) in patients with PE(16 cases) and the effects of SS-cream on SEP for treating PE. The latencies and amplitudes of the evoked responses were measured by two different places in stimuli, one was on the penile shaft with ring electrode and the other on the glans penis with a surface electrode. The latency of SEP stimulated at the glans penis was significantly longer than that stimulated at the penile shaft (p 0.05). The amplitudes of the evoked responses stimulated at the glans penis were significantly higher than those stimulated at penile shaft (p< 0.05). And both these amplitudes were significantly reduced with the application of SS-cream (p< 0.05). With these result, we can suggest that the patients with PE have glans penile hyperexcitability and it provides further implications for an organic basis of PE, SEP stimulated at the glans penis can be a very useful method to evaluate PE, along with SEP stimulated a penile shaft and SS-cream prolongs the sensory conduction and reduces the penile hyperexcitability of the patient with PE.


Sujets)
Adulte , Humains , Mâle , Médicaments issus de plantes chinoises/usage thérapeutique , Éjaculation/effets des médicaments et des substances chimiques , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Adulte d'âge moyen , Dysfonctionnements sexuels psychogènes/traitement médicamenteux
7.
Arch. invest. méd ; 18(1): 51-67, ene.-mar. 1987. ilus, tab
Article Dans Espagnol , Anglais | LILACS | ID: lil-55962

Résumé

Se estudia el efecto del fentanyl (9.46 nmol/Kg) y la naloxona (5.50 nmol/Kg) sobre la amplitud, área y latencia de los potenciales evocados auditivos, con el objeto de establecer su mecanismo de acción electrofisiológico. Se estudiaron 110 pacientes adultos, mediante tres paradigmas farmacológicos: 1. Control inicial (C), solución salina (S) y control final (C'). 2. C, fentanyl (F) y C'. 3. C, naloxona (N) y C'. El fentanyl disminuyó la amplitud y área de los P150 y P300; mientras que la naloxona aumentó la amplitud y área de los P130 y P300 pequeños (S), y tuvo el efecto contrario sobre los P300 grandes (L); en contraste, no afectaron los PI, PV y P50. Se concluye que el fentanyl disminuye el proceso de atención selectiva y que efecto bidireccional de la naloxona probablemente se relacione con el grado de desarrollo del sistema opioide endógeno


Sujets)
Audiométrie électroencéphalographique , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Fentanyl/pharmacologie , Fentanyl/administration et posologie , Naloxone/administration et posologie , Naloxone/pharmacologie
8.
Arch. invest. méd ; 16(supl 3): 115-31, 1985. ilus, tab
Article Dans Espagnol , Anglais | LILACS | ID: lil-37040

Résumé

Se valoró el efecto de la hormona estimulante de melanocitos (MSH) sobre la atención selectiva en el hombre por medio de los cambios de amplitud en los componentes temprano y tardío de los potenciales somáticos evocados (PSE). Se tuvo cuidado especial de valorar los cambios concomitantes en el nivel de alerta general y en las pruebas de memoria reciente o de discriminación espacial. Este efecto se comparó con los producidos por fármacos del tipo de la noradrenalina (dextroanfetamina) y morfínicos (fentanil y naloxona). Ninguno de estos compuestos cambió la amplitud de los PSE tempranos, pero modificaron de manera diferencial los tardíos; la MSH y la naloxona aumentaron la amplitud de los PSE tardíos, en tanto que la dextroanfetamina y el fentanil la disminuyeron. La MSH y la naloxona aumentaron la velocidad de reacción, lo mismo que las pruebas de retención visual y discriminación espacial, sin cambios en el nivel de alerta general. La dextroanfetamina y el fentanil disminuyeron las pruebas de retención visual o de discriminación espacial, pero en tanto la primera aumentó la velocidad de reacción y el estado de alerta general, la última disminuyó la velocidad de reacción sin producir cambios en el estado de alerta general. Estos dados sugieren que MSH y otros compuestos relacionados producen cambios en el proceso de la atención del hombre al modificar la excitabilidad de los componentes tardíos de los PSE mediadores del sistema extralemniscal, pero no los propios del sistema lemnisco. Sugieren además que los cambios producidos en los PSE por MSH, fentanil y naloxona ocurrieron a nivel cortical pero no en la parte reticular del sistema extralemniscal, puesto que estos compuestos modificaron la velocidad de reacción y las pruebas de retención visual o de discriminación espacial (parte cortical) sin cambios en el nivel de alerta general (parte reticular). Sin embargo, los cambios producidos por la destroanfetamina en los PSE tardíos y la atención, deben considerarse consecuencias de la activación de los circuitos reticular y motor, que son independientes del relacionado con la atención selectiva


Sujets)
Humains , Attention/effets des médicaments et des substances chimiques , Potentiels évoqués somatosensoriels/effets des médicaments et des substances chimiques , Hormones mélanotropes/pharmacologie , Dexamfétamine/pharmacologie , Fentanyl/pharmacologie , Apprentissage/effets des médicaments et des substances chimiques , Naloxone/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche